Home > Quotes > DRTX > Press Releases
DRTX

Durata Therapeutics, Inc. Press Releases

$7.15
*  
0.01
  negative  
0.14%
Get DRTX Alerts
*Delayed - data as of May 17, 2013 
Exchange: NASDAQ
Industry: Consumer Durables
Community Rating:
 
 

Symbol List Views

Stock Details

CHARTS

COMPANY NEWS

STOCK ANALYSIS

FUNDAMENTALS

HOLDINGS

Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.


Don't know the stock symbol? Use the symbol lookup tool.

Alphabetize the sort order of my symbols 
Symbol Lookup
Log in or Register
 Save stocks for next time
 | Sponsored
Viewing
Filtered By
Ordered By

Paul A. Friedman, M.D. is Elected to Durata Therapeutics' Board of Directors
05/16/2013 1:44PM - GlobeNewswire

Durata Therapeutics, Inc. Reports First Quarter 2013 Financial Results
05/09/2013 7:00AM - GlobeNewswire

Durata Therapeutics to Present at Bank of America Merrill Lynch 2013 Healthcare Conference
05/07/2013 7:30AM - GlobeNewswire

Durata Therapeutics to Announce First Quarter 2013 Financial Results on May 9, 2013
05/02/2013 7:30AM - GlobeNewswire

Sofinnova Ventures Announces Team Expansion and Promotion
05/02/2013 6:00AM - PR Newswire

New Data Demonstrating In Vitro Potency of Dalbavancin Against Bacterial Pathogens Presented at the 23rd Annual ECCMID Meeting
04/29/2013 7:30AM - GlobeNewswire

Phase I Data Evaluating Safety, Tolerability and Pharmacokinetics of Multiple Weekly Doses of Dalbavancin Presented at the 23rd Annual ECCMID Meeting
04/29/2013 7:30AM - GlobeNewswire

Durata Therapeutics to Present Two Dalbavancin Posters at the 23rd Annual ECCMID Meeting
04/24/2013 7:30AM - GlobeNewswire

Durata Therapeutics to Present at the 2013 Needham Healthcare Conference
04/22/2013 3:30PM - GlobeNewswire

Durata Therapeutics Closes Public Offering of Common Stock
04/17/2013 4:15PM - GlobeNewswire

Durata Therapeutics Prices Public Offering of Common Stock
04/12/2013 7:30AM - GlobeNewswire

Durata Therapeutics to Host Reimbursement Seminar on April 23, 2013
04/02/2013 3:30PM - GlobeNewswire

Durata Therapeutics, Inc. Reports Full-Year 2012 Financial Results
03/08/2013 7:00AM - GlobeNewswire

Durata Therapeutics to Announce Full Year 2012 Financial Results on Friday, March 8, 2013
03/05/2013 4:30PM - GlobeNewswire

Durata Therapeutics Announces Preliminary, Topline Phase 3 Clinical Trial Results for Dalbavancin in the Treatment of ABSSSI
02/25/2013 7:00AM - GlobeNewswire

Durata Therapeutics to Present at the Cowen & Company 33rd Annual Health Care Conference
02/20/2013 2:00PM - GlobeNewswire